Association between Escherichia coli with NotI-restriction resistance and urinary tract infections

J Microbiol Immunol Infect. 2022 Aug;55(4):686-694. doi: 10.1016/j.jmii.2021.11.010. Epub 2021 Dec 16.

Abstract

Background: Escherichia coli is the most common cause of urinary tract infections (UTIs). It is widely accepted that uropathogenic E. coli (UPEC) mainly emerge from the distal gut microbiota. Identification of bacterial characteristics that are able to differentiate UPEC from fecal commensal strains will facilitate the development of novel strategies to detect and monitor the spread of UPEC.

Methods: Fifty fecal commensal, 83 UTI-associated and 40 biliary tract infection (BTI)-associated E. coli isolates were analyzed. The NotI restriction patterns of chromosomal DNA in the isolates were determined by pulse-field gel electrophoresis. The phylogenetic types and the presence of 9 known virulence genes of each isolate were determined by PCR analyses. Additionally, the susceptibilities of the isolates to antibiotics were revealed. Then the associations of NotI resistance with UTI-associated isolates, phylotypes, and antibiotic resistance were assessed.

Results: NotI resistance was correlated with UTI-associated isolates, compared to the fecal isolates. Consistently, NotI-resistant isolates harbored a greater number of virulence factors and mainly belonged to phylotype B2. Additionally NotI resistance was correlated with chloramphenicol resistance among the bacteria. Among the fecal, UTI-associated and BTI-associated groups, the distribution of NotI-resistant group B2 isolates was correlated with UTI-associated bacteria.

Conclusion: NotI resistance alone is a potential marker for distinguishing fecal strains and UPEC, while the combination of NotI resistance and B2 phylogeny is a candidate marker to differentiate UPEC from fecal and other extraintestinal pathogenic E. coli. Additionally, NotI resistance may be valuable for assessing the potential of chloramphenicol resistance of E. coli.

Keywords: NotI; PFGE; Phylogenetic group B2; RFLP; Restriction enzyme resistance; Urinary tract infection; Uropathogenic E. coli.

MeSH terms

  • Anti-Bacterial Agents
  • Escherichia coli Infections*
  • Humans
  • Phylogeny
  • Urinary Tract Infections*
  • Uropathogenic Escherichia coli*
  • Virulence Factors

Substances

  • Anti-Bacterial Agents
  • Virulence Factors